First-in-human imaging with 89Zr-Df-IAB2M anti-PSMA minibody in patients with metastatic prostate cancer: Pharmacokinetics, Biodistribution, Dosimetry, and Lesion Uptake. J Nucl Med. 2016;57:1858-1864.Pandit-Taskar N, O'Donoghue JA, Ruan S, et al. First-in-human imaging with 89Zr-Df-...